Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy

E. Santagostino, P. M. Mannucci, A. Bianchi Bonomi

Research output: Contribution to journalArticle

Abstract

In the last years, the availability in Italy of technologically advanced products for replacement therapy has produced significant changes in the management of haemophilia and of hereditary bleeding disorders in general. With the aim of a uniform approach to treatment, the Italian Association of Haemophilia Centres express in these guidelines a consensus on therapeutic strategies designed to ensure the highest degree of safety and efficacy for the treatment of inherited coagulopathies. The guidelines provide specific recommendations for the choice of the product according to updated scientific evidence, and advice on optimal dosages for the treatment of rare bleeding disorders. The system for haemophilia care and funding in Italy is briefly described.

Original languageEnglish
Pages (from-to)1-10
Number of pages10
JournalHaemophilia
Volume6
Issue number1
DOIs
Publication statusPublished - 2000

Keywords

  • Guidelines
  • Haemophilia
  • Inherited coagulation disorders
  • Therapeutic products
  • Treatment

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy'. Together they form a unique fingerprint.

  • Cite this